Industry Voices—The diabetes complication that causes immeasurable harm is often only just the beginning
More than 35 million Americans have been diagnosed with diabetes, and the country spends Read more…
News
Empirical Spine Closes $10 Million Series B Financing — Empirical Spine
SAN CARLOS, Calif., June 2, 2021 /PRNewswire/ — Empirical Spine, Inc., maker of the LimiFlex Paraspinous Tension Band, today announced the closing of a Series B financing of $10 million. SHD (Scientific Health Development) led the round, with additional investment from GP&G (Green Park & Golf) and other syndicate members. The funds will be used
Empirical Spine Closes $10 Million Series B Financing — Empirical Spine Read More »
New Indication for Lymphedema in Lower Extremities
Dayspring compression therapy system is now FDA cleared for treatment of lymphedema and venous diseases in both upper and lower extremities Koya Medical strengthens leadership team with appointments of three industry veterans to support commercial expansion OAKLAND, Calif., May 26, 2021 — Koya Medical, a healthcare company focused on developing breakthrough treatments for lymphedema and
New Indication for Lymphedema in Lower Extremities Read More »
Procyrion Announces Successful First-in-Human Cases in Cardiorenal Syndrome (CRS) Patients with Aortix™ Percutaneous Mechanical Circulatory Support Device
Pilot CRS Study to Evaluate Performance of Novel Aortix device in Australia and the U.S. HOUSTON, TX – MAY 25, 2021 – Procyrion, Inc., a medical device company dedicated to improving outcomes for patients with cardiac and renal impairment, announced today successful treatment of the first patients in the company’s pilot trial to evaluate the
Koya Medical Presents at Oppenheimer MedTech
OAKLAND, Calif., May 20, 2021 — Koya Medical, a healthcare company focused on developing breakthrough treatments for lymphedema and venous diseases, will present at the Oppenheimer MedTech, Tools & Diagnostics Summit on Wednesday, May 26, 2021. Koya Founder, CEO and President Andy Doraiswamy, Ph.D., will provide an overview of Koya’s recent business milestones and developments
Koya Medical Presents at Oppenheimer MedTech Read More »
TAKE FIVE: EIRION’S JON EDELSON, MD
MODERN AESTHETICS® NEWS ? If you haven’t heard of Eirion Therapeutics yet, you will. That’s a promise. Headquartered in Woburn, MA, the aesthetic dermatology company boasts a disruptive pipeline focusing on treatments for wrinkles, primary axillary hyperhidrosis, androgenic alopecia, and hair graying and just scored some major financing. Jon Edelson, MD, Eirion’s Chairman, CEO, and
TAKE FIVE: EIRION’S JON EDELSON, MD Read More »
Eirion Therapeutics, Inc. Closes $40 Million Series A Investment and Licensing Deal with Shanghai Ha
WOBURN, Mass, March 9, 2021 /PRNewswire/ Today, Eirion Therapeutics, Inc., an aesthetic dermatology company headquartered in Woburn, Massachusetts, announced a deal with Shanghai Haohai Biological Technology Ltd. (“Haohai”) that will result in a $32 million Series A Preferred Stock investment into Eirion along with exclusive licenses that will be for all of Eirion’s products for
Empirical Spine Receives FDA Breakthrough Device Designation for the LimiFlex Device Targeting Degenerative Spondylolisthesis — Empirical Spine
Empirical Spine, Inc., a company developing advanced solutions for the surgical treatment of spinal disorders, today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device Designation (BDD) for its LimiFlex™ Paraspinous Tension Band. In doing so, the FDA has determined that LimiFlex™ holds the potential to offer significant advantages over existing
Medical Tech Leader Joins Koya Medical Board
OAKLAND, Calif., March 4, 2021 — Koya Medical, a healthcare company focused on developing breakthrough treatments for lymphedema and venous disorders, today announced the appointment of Ali Bauerlein to its Board of Directors. Ms. Bauerlein brings more than 20 years of experience in the medical technology space as the CFO and co-founder of Inogen, Inc.
Medical Tech Leader Joins Koya Medical Board Read More »
Empirical Spine Initiates PMA Submission Process for FDA Approval of Limiflex for Degenerative Spondylolisthesis — Empirical Spine
Empirical Spine, Inc., maker of the LimiFlex™ Paraspinous Tension Band, today announced initiation of the PMA process for FDA review and approval of the use of the LimiFlex with a decompression for patients suffering from degenerative spondylolisthesis with lumbar spinal stenosis. The Pivotal Trial supporting the PMA compares outcomes of patients who receive either LimiFlex